Literature DB >> 16905282

Bioavailability of salvianolic acid B in conscious and freely moving rats.

Yu-Tse Wu1, Yen-Fei Chen, Yen-Ju Hsieh, Ine Jaw, Ming-Shi Shiao, Tung-Hu Tsai.   

Abstract

Salvianolic acid B is an herbal ingredient isolated from Salvia miltiorrhiza. The aim of this study was to apply an automated blood sampling system coupled to a simple liquid chromatographic system to determine the bioavailability of salvianolic acid B in stress-free rats. The plasma sample (25 microl) was vortex-mixed with 50 microl of internal standard solution (chloramphenicol 10 microg/ml in acetonitrile) to achieve protein precipitation. Salvianolic acid B in the rat plasma was separated using a reversed-phase C18 column (250 mm x 4.6 mm, 5 microm) with a mobile phase of acetonitrile-methanol-20mM NaH(2)PO(4) (adjusted to pH 3.5 with H(3)PO(4)) (20:10:70 v/v/v) containing 0.1mM 1-octanesulfonic acid, and the flow-rate of 1 ml/min. The UV detection wavelength was 286 nm. The concentration-response relationship from the present method indicated linearity over a concentration range of 0.5-200 microg/ml. Intra- and inter-assay precision and accuracy of salvianolic acid B fell well within the predefined limits of acceptability (<15%). The plasma sample of salvianolic acid B was further identified by LC-MS/MS in the negative ion mode using mass transition m/z 358.2 to the product ion m/z 196.9. After salvianolic acid B (100mg/kg, i.v.; 500 mg/kg, p.o.) was given in conscious and freely moving rats, the AUC were 5030+/-565 and 582+/-222 min microg/ml for intravenous (100 mg/kg) and oral (500 mg/kg) doses, respectively. The oral bioavailability of salvianolic acid B in freely moving rats was calculated to be 2.3%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16905282     DOI: 10.1016/j.ijpharm.2006.07.003

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  14 in total

1.  Metabolic profile of danshen in rats by HPLC-LTQ-Orbitrap mass spectrometry.

Authors:  Huan-Huan Pang; Mei-Fang Jiang; Qin-Hui Wang; Xiao-Ye Wang; Wei Gao; Zhi-Hao Tian; Jian-Mei Huang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

2.  Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis.

Authors:  Peng Lu; Jiawei Li; Chuanxin Liu; Jian Yang; Hui Peng; Zhifeng Xue; Zhidong Liu
Journal:  Asian J Pharm Sci       Date:  2022-04-30       Impact factor: 9.273

3.  Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter-Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway.

Authors:  Yan Guan; Liucheng Li; Liandi Kan; Qiangmin Xie
Journal:  Oxid Med Cell Longev       Date:  2022-06-27       Impact factor: 7.310

Review 4.  Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection.

Authors:  Jennifer Hui-Chun Ho; Chuang-Ye Hong
Journal:  J Biomed Sci       Date:  2011-05-11       Impact factor: 8.410

5.  Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases.

Authors:  Wei Zhou; Jinan Wang; Ziyin Wu; Chao Huang; Aiping Lu; Yonghua Wang
Journal:  Sci Rep       Date:  2016-11-14       Impact factor: 4.379

6.  Salvianolic Acid B Alleviates Heart Failure by Inactivating ERK1/2/GATA4 Signaling Pathway after Pressure Overload in Mice.

Authors:  Juan Yu; Renshan Chen; Yafang Tan; Jiashin Wu; Jianyong Qi; Minzhou Zhang; Weiwang Gu
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 7.  Salvia miltiorrhiza Roots against Cardiovascular Disease: Consideration of Herb-Drug Interactions.

Authors:  Feng Chen; Li Li; Dan-Dan Tian
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

8.  Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.

Authors:  Pradeep Paudel; Su Hui Seong; Yajuan Zhou; Chan Hum Park; Takako Yokozawa; Hyun Ah Jung; Jae Sue Choi
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

9.  A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.

Authors:  Xiuxiu Li; Xue Xu; Jinan Wang; Hua Yu; Xia Wang; Hongjun Yang; Haiyu Xu; Shihuan Tang; Yan Li; Ling Yang; Luqi Huang; Yonghua Wang; Shengli Yang
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Pharmacokinetic study of salvianolic acid D after oral and intravenous administration in rats.

Authors:  Junke Song; Wen Zhang; Jialin Sun; Xiaona Xu; Xue Zhang; Li Zhang; Zhangying Feng; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2015-04-27       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.